DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Sitaxentan is an investigational drug.
There have been 10 clinical trials for Sitaxentan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Hypertension, Familial Primary Pulmonary Hypertension, and Hypertension, Pulmonary. The leading clinical trial sponsors are Pfizer, Institut National de la Santé Et de la Recherche Médicale, France, and Encysive Pharmaceuticals.
Recent Clinical Trials for Sitaxentan
|Drug Interaction Between Ritonavir And Sitaxsentan||Pfizer||Phase 1|
|Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients||Pfizer||Phase 3|
|A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses||Pfizer||Phase 1|